Crosstalk between aldehyde dehydrogenase-1 and chemoresistance in breast cancer: Insights into the role of vitamin D3
- 28 April 2020
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 253, 117733
Abstract
No abstract availableKeywords
Funding Information
- British University in Egypt
This publication has 30 references indexed in Scilit:
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironmentBreast Cancer Research and Treatment, 2009
- Vitamin D and differentiation in cancerCritical Reviews in Clinical Laboratory Sciences, 2009
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progressionEndocrine-Related Cancer, 2007
- Cancer Immunologists and Cancer Biologists: Why We Didn't Talk Then but Need to NowCancer Research, 2007
- Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblastsHuman Reproduction Update, 2006
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981